| Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status L Formisano, V D'Amato, A Servetto, S Brillante, L Raimondo, C Di Mauro, ... Oncotarget 6 (28), 26090, 2015 | 39 | 2015 |
| Regulation of autophagosome biogenesis by OFD1‐mediated selective autophagy M Morleo, S Brillante, U Formisano, L Ferrante, F Carbone, D Iaconis, ... The EMBO Journal 40 (4), e105120, 2021 | 26 | 2021 |
| Integrated genomics identifies miR-181/TFAM pathway as a critical driver of drug resistance in melanoma A Barbato, A Iuliano, M Volpe, R D’Alterio, S Brillante, F Massa, ... International Journal Of Molecular Sciences 22 (4), 1801, 2021 | 21 | 2021 |
| A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant C Mandato, MA Siano, L Nazzaro, M Gelzo, P Francalanci, F Rizzo, ... Orphanet journal of rare diseases 16, 1-9, 2021 | 20 | 2021 |
| The HOPS complex subunit VPS39 controls ciliogenesis through autophagy D Iaconis, C Crina, S Brillante, A Indrieri, M Morleo, B Franco Human Molecular Genetics 29 (6), 1018-1029, 2020 | 16 | 2020 |
| The VersaLive platform enables microfluidic mammalian cell culture for versatile applications GM Nocera, G Viscido, S Criscuolo, S Brillante, F Carbone, L Staiano, ... Communications biology 5 (1), 1034, 2022 | 7 | 2022 |
| miR‐181a/b downregulation: a mutation‐independent therapeutic approach for inherited retinal diseases S Carrella, M Di Guida, S Brillante, D Piccolo, L Ciampi, I Guadagnino, ... EMBO Molecular Medicine 14 (11), e15941, 2022 | 4 | 2022 |
| Biallelic variants in CENPF causing a phenotype distinct from Strømme syndrome G Cappuccio, S Brillante, R Tammaro, M Pinelli, ML De Bernardi, ... American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2022 | 4 | 2022 |
| Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma P Carotenuto, A Romano, A Barbato, P Quadrano, S Brillante, M Volpe, ... Cell Reports 41 (6), 2022 | 3 | 2022 |
| From the Sea for the Sight: Marine Derived Products for Human Vision S Brillante, C Galasso, C Lauritano, S Carrella Frontiers in Aging Neuroscience 14, 892764, 2022 | 3 | 2022 |
| The VersaLive platform enables pipette-compatible microfluidic mammalian cell culture for versatile applications GM Nocera, G Viscido, S Brillante, S Carrella, D di Bernardo bioRxiv, 2021.07. 02.450869, 2021 | 3 | 2021 |
| Drug Repurposing to Target the Apoptosome in MAPKi-Resistant Melanoma P Carotenuto, A Romano, A Barbato, P Quadrano, S Brillante, M Volpe, ... | 1 | 2021 |
| A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers A Barbato, F Piscopo, M Salati, C Pollastro, L Evangelista, L Ferrante, ... Clinical and Experimental Medicine 24 (1), 74, 2024 | | 2024 |
| AAV-mediated inhibition of miR-181a/b as a gene-independent therapeutic tool for LHON M Volpe, S Barbato, S Brillante, R Tammaro, E Marrocco, S Carrella, ... Investigative Ophthalmology & Visual Science 64 (8), 1918-1918, 2023 | | 2023 |
| miR-181a/b modulation as potential therapeutic approach for AMD treatment S Brillante, E Cipollaro, A Diana, M Molinari, M Volpe, C Damiano, ... Investigative Ophthalmology & Visual Science 64 (8), 2113-2113, 2023 | | 2023 |
| Author Correction: The VersaLive platform enables microfluidic mammalian cell culture for versatile applications GM Nocera, G Viscido, S Criscuolo, S Brillante, F Carbone, L Staiano, ... Communications Biology 5, 2022 | | 2022 |
| AAV-Sponge-mediated modulation of miR-181a/b as a gene-independent therapeutic approach for inherited retinal diseases (IRDs) S Carrella, M Di Guida, D Piccolo, L Ciampi, M Pizzo, M Molinari, ... HUMAN GENE THERAPY 32 (19-20), A125-A126, 2021 | | 2021 |
| THE OFD1 PROTEIN CONTROLS AUTOPHAGOSOME BIOGENESIS THROUGH SELECTIVE AUTOPHAGY S Brillante Università degli Studi di Milano, 2020 | | 2020 |
| 74P Targeting mitochondria as a novel therapeutic strategy in biliary tract cancer P Carotenuto, A Barbato, A Indrieri, M Volpe, P Quadrano, S Brillante, ... Annals of Oncology 31, S269, 2020 | | 2020 |
| Autophagy inhibition ameliorates renal cystic disease in OFD type I syndrome M Morleo, U Formisano, S Brillante, D Iaconis, S Maione, E Damiano, ... EUROPEAN JOURNAL OF HUMAN GENETICS 27, 74-74, 2019 | | 2019 |
